Neutrophil to Lymphocyte Ratio in Epilepsy: A Systematic Review

This study was conducted to summarize the results of studies investigating the role of neutrophil to lymphocyte ratio (NLR) in epilepsy. The search was conducted on PubMed, Scopus, and Web of Science up to December 25, 2021. Finally, a total of seven studies were included in the review. The NLR in patients who were in the acute phase was higher than that of healthy. NLR in the patients who were in either acute or subacute phase was higher than in healthy controls. A significant difference in NLR levels between the acute and subacute phases was also noted. Epilepsy is one of the most important neurological diseases in the world, and millions of people around the world suffer from it, and a cheap and fast biomarker is needed for it. The interesting thing is that inflammation plays a role in epilepsy, and elevated NLR value can be a good biomarker of inflammation and, as a result, for epilepsy.

[1]  E. Engleman,et al.  Brain profiling in murine colitis and human epilepsy reveals neutrophils and TNFα as mediators of neuronal hyperexcitability , 2021, Journal of Neuroinflammation.

[2]  G. Aktas Hematological predictors of novel Coronavirus infection. , 2021, Revista da Associacao Medica Brasileira.

[3]  C. Sala,et al.  A literature overview on epilepsy and inflammasome activation , 2021, Brain Research Bulletin.

[4]  G. Morkavuk,et al.  Is the differential diagnosis of epilepsy and psychogenic nonepileptic seizures possible by assessing the neutrophil/lymphocyte ratio? , 2021, Epilepsy & Behavior.

[5]  G. Aktas,et al.  Platelet to Lymphocyte and Neutrophil to Lymphocyte Ratios are useful in differentiation of thyroid conditions with normal and increased uptake , 2021 .

[6]  A. Vezzani,et al.  Inflammation and reactive oxygen species as disease modifiers in epilepsy , 2020, Neuropharmacology.

[7]  Muzaffer Güneş,et al.  Relationship between generalized epileptic seizure and neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and neutrophil mediated inflammation , 2020, The International journal of neuroscience.

[8]  A. Aslan,et al.  Critical analysis of blood parameters in epilepsy patients , 2020 .

[9]  S. Yeni,et al.  Serum Endocan and Preoperative Systemic Inflammatory Markers in Patients with Epilepsy. , 2020, Neuro-chirurgie.

[10]  M. Kocak,et al.  Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus , 2019, African health sciences.

[11]  A. Musto,et al.  The role of inflammation in the development of epilepsy , 2018, Journal of Neuroinflammation.

[12]  M. Çalık,et al.  Effect of serum inflammatory markers on the prognosis of adult and pediatric patients with Guillain–Barré syndrome , 2018, Neuropsychiatric disease and treatment.

[13]  Ming Chen,et al.  Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study. , 2017, Journal of neurosurgery.

[14]  S. Yeni,et al.  Preoperative Systemic Inflammatory Markers in Different Brain Pathologies: An Analysis of 140 Patients. , 2018, Turkish neurosurgery.

[15]  B. Silva,et al.  Brain expression of inflammatory mediators in Mesial Temporal Lobe Epilepsy patients , 2017, Journal of Neuroimmunology.

[16]  H. Erkol,et al.  Elevated neutrophil-to-lymphocyte ratio in the diagnosis of Hashimoto's thyroiditis. , 2017, Revista da Associacao Medica Brasileira.

[17]  S. Varol,et al.  Changes in serum albumin levels and neutrophil–lymphocyte ratio in patients with convulsive status epilepticus , 2017, The International journal of neuroscience.

[18]  Shekhar Saxena,et al.  Defeating epilepsy: A global public health commitment , 2017, Epilepsia open.

[19]  S. Yildiz,et al.  Hemogram parameters in epilepsy may be indicators of chronic inflammation and hypoxemia , 2017 .

[20]  R. Ransohoff,et al.  Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticus , 2016, Proceedings of the National Academy of Sciences.

[21]  H. Keskin,et al.  Elevated neutrophil-lymphocyte ratio in patients with euthyroid chronic autoimmune thyreotidis , 2016, Endocrine regulations.

[22]  M. Avoli,et al.  Does angiogenesis play a role in the establishment of mesial temporal lobe epilepsy? , 2016, International Journal of Developmental Neuroscience.

[23]  F. Cendes,et al.  Peripheral leukocyte profile in people with temporal lobe epilepsy reflects the associated proinflammatory state , 2016, Brain, Behavior, and Immunity.

[24]  Abigail R. Colson,et al.  Health and economic benefits of public financing of epilepsy treatment in India: An agent‐based simulation model , 2016, Epilepsia.

[25]  S. Kutluhan,et al.  The clinical significance of the neutrophil-to-lymphocyte ratio in multiple sclerosis , 2015, The International journal of neuroscience.

[26]  W. Löscher,et al.  Infections, inflammation and epilepsy , 2016, Acta Neuropathologica.

[27]  S. Alan,et al.  The relation of neutrophil‐to‐lymphocyte ratio, platelet‐to‐lymphocyte ratio, and mean platelet volume with the presence and severity of Behçet's syndrome , 2015, The Kaohsiung journal of medical sciences.

[28]  Qingchang Li,et al.  Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma , 2015, BMC Cancer.

[29]  Philippe Ryvlin,et al.  Epilepsy: new advances , 2015, The Lancet.

[30]  Y. Bayoğlu Tekin,et al.  Neutrophil‐to‐lymphocyte and platelet‐to‐lymphocyte ratios in patients with endometrial hyperplasia and endometrial cancer , 2015, The journal of obstetrics and gynaecology research.

[31]  H. Özdemir,et al.  The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil/lymphocyte ratio in Parkinson’s disease , 2015, Neurological Sciences.

[32]  E. Felip,et al.  Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer , 2012, Clinical and Translational Oncology.

[33]  M Lindsay,et al.  Epilepsy in adults. , 1983, Nursing.